- Home
- MGYR vs VIGL Comparison
MGYR vs VIGL Comparison
Compare MGYR & VIGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGYR
- VIGL
- Stock Information
- Founded
- MGYR 1922
- VIGL 2020
- Country
- MGYR United States
- VIGL United States
- Employees
- MGYR N/A
- VIGL N/A
- Industry
- MGYR Savings Institutions
- VIGL Biotechnology: Pharmaceutical Preparations
- Sector
- MGYR Finance
- VIGL Health Care
- Exchange
- MGYR Nasdaq
- VIGL Nasdaq
- Market Cap
- MGYR 94.1M
- VIGL 89.3M
- IPO Year
- MGYR 2006
- VIGL 2022
- Fundamental
- Price
- MGYR $13.95
- VIGL $1.71
- Analyst Decision
- MGYR
- VIGL Strong Buy
- Analyst Count
- MGYR 0
- VIGL 5
- Target Price
- MGYR N/A
- VIGL $16.33
- AVG Volume (30 Days)
- MGYR 2.5K
- VIGL 142.8K
- Earning Date
- MGYR 04-29-2025
- VIGL 05-06-2025
- Dividend Yield
- MGYR 1.82%
- VIGL N/A
- EPS Growth
- MGYR 10.61
- VIGL N/A
- EPS
- MGYR 1.30
- VIGL N/A
- Revenue
- MGYR $32,424,000.00
- VIGL N/A
- Revenue This Year
- MGYR N/A
- VIGL N/A
- Revenue Next Year
- MGYR N/A
- VIGL N/A
- P/E Ratio
- MGYR $10.70
- VIGL N/A
- Revenue Growth
- MGYR 7.24
- VIGL N/A
- 52 Week Low
- MGYR $10.66
- VIGL $1.31
- 52 Week High
- MGYR $14.90
- VIGL $6.06
- Technical
- Relative Strength Index (RSI)
- MGYR 48.87
- VIGL 47.15
- Support Level
- MGYR $13.52
- VIGL $1.31
- Resistance Level
- MGYR $13.84
- VIGL $1.66
- Average True Range (ATR)
- MGYR 0.11
- VIGL 0.17
- MACD
- MGYR 0.02
- VIGL 0.03
- Stochastic Oscillator
- MGYR 68.25
- VIGL 71.33
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families. Its clinical candidate, iluzanebart, is currently being studied in IGNITE, a Phase 2 PoC trial and the first-ever interventional trial in ALSP patients. The company is also developing VG-3927, an orally available small molecule TREM2 agonist for the treatment of common neurodegenerative diseases associated with microglial dysfunction.